Page last updated: 2024-08-17

xanthone and Angiogenesis, Pathologic

xanthone has been researched along with Angiogenesis, Pathologic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ding, Q; Hung, MC; Lin, CN; Pan, SL; Sun, HL; Teng, CM; Tsai, AC; Yamaguchi, H1

Other Studies

1 other study(ies) available for xanthone and Angiogenesis, Pathologic

ArticleYear
EPOX inhibits angiogenesis by degradation of Mcl-1 through ERK inactivation.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2009, Aug-01, Volume: 15, Issue:15

    Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Apoptosis Regulatory Proteins; Cell Survival; Cells, Cultured; Endothelial Cells; Endothelium, Vascular; Epoxy Compounds; Extracellular Signal-Regulated MAP Kinases; Glutathione; Humans; Mice; Mice, Nude; Mitochondria; Myeloid Cell Leukemia Sequence 1 Protein; Neovascularization, Pathologic; Proto-Oncogene Proteins c-bcl-2; Umbilical Veins; Xanthones; Xenograft Model Antitumor Assays

2009